Last reviewed · How we verify
Placebo 100 (for Aspirin 100) — Competitive Intelligence Brief
phase 3
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo 100 (for Aspirin 100) (Placebo 100 (for Aspirin 100)) — Assistance Publique - Hôpitaux de Paris. This is a placebo control formulation used in clinical trials to compare against Aspirin 100 mg.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo 100 (for Aspirin 100) TARGET | Placebo 100 (for Aspirin 100) | Assistance Publique - Hôpitaux de Paris | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo 100 (for Aspirin 100) CI watch — RSS
- Placebo 100 (for Aspirin 100) CI watch — Atom
- Placebo 100 (for Aspirin 100) CI watch — JSON
- Placebo 100 (for Aspirin 100) alone — RSS
Cite this brief
Drug Landscape (2026). Placebo 100 (for Aspirin 100) — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-100-for-aspirin-100. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab